1. Home
  2. SGMT vs GASS Comparison

SGMT vs GASS Comparison

Compare SGMT & GASS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGMT
  • GASS
  • Stock Information
  • Founded
  • SGMT 2006
  • GASS 2004
  • Country
  • SGMT United States
  • GASS Greece
  • Employees
  • SGMT N/A
  • GASS N/A
  • Industry
  • SGMT
  • GASS Marine Transportation
  • Sector
  • SGMT
  • GASS Consumer Discretionary
  • Exchange
  • SGMT Nasdaq
  • GASS Nasdaq
  • Market Cap
  • SGMT 238.7M
  • GASS 243.4M
  • IPO Year
  • SGMT 2023
  • GASS 2005
  • Fundamental
  • Price
  • SGMT $8.30
  • GASS $6.57
  • Analyst Decision
  • SGMT Strong Buy
  • GASS
  • Analyst Count
  • SGMT 8
  • GASS 0
  • Target Price
  • SGMT $26.88
  • GASS N/A
  • AVG Volume (30 Days)
  • SGMT 651.1K
  • GASS 102.6K
  • Earning Date
  • SGMT 11-13-2025
  • GASS 11-24-2025
  • Dividend Yield
  • SGMT N/A
  • GASS N/A
  • EPS Growth
  • SGMT N/A
  • GASS N/A
  • EPS
  • SGMT N/A
  • GASS 1.64
  • Revenue
  • SGMT N/A
  • GASS $173,172,375.00
  • Revenue This Year
  • SGMT N/A
  • GASS $2.45
  • Revenue Next Year
  • SGMT N/A
  • GASS N/A
  • P/E Ratio
  • SGMT N/A
  • GASS $3.98
  • Revenue Growth
  • SGMT N/A
  • GASS 13.82
  • 52 Week Low
  • SGMT $1.73
  • GASS $4.82
  • 52 Week High
  • SGMT $11.41
  • GASS $8.18
  • Technical
  • Relative Strength Index (RSI)
  • SGMT 54.70
  • GASS 49.43
  • Support Level
  • SGMT $8.02
  • GASS $6.33
  • Resistance Level
  • SGMT $9.46
  • GASS $6.58
  • Average True Range (ATR)
  • SGMT 0.62
  • GASS 0.17
  • MACD
  • SGMT 0.07
  • GASS 0.04
  • Stochastic Oscillator
  • SGMT 45.67
  • GASS 72.34

About SGMT Sagimet Biosciences Inc. Series A

Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.

About GASS StealthGas Inc.

StealthGas Inc is an international shipping transportation company. It owns liquefied petroleum gas (LPG) pressurized carriers and provides international seaborne transportation services to LPG producers and users, as well as crude oil and product carriers to oil producers, refineries, and commodities traders. The company carriers carry various petroleum gas products in liquefied forms, such as propane, butane, butadiene, isopropane, propylene, and vinyl chloride monomer, which are all byproducts of the production of crude oil and natural gas.

Share on Social Networks: